United Health Pr Financials

UEEC

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows United Health Pr (UEEC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak

3/9

United Health Pr passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality

0.60x

For every $1 of reported earnings, United Health Pr generates $0.60 in operating cash flow (-$1.2M OCF vs -$2.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-62.1x

United Health Pr earns $-62.1 in operating income for every $1 of interest expense (-$2.0M vs $32K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Revenue

United Health Pr generated $0 in revenue in fiscal year 2024.

EBITDA

-$2.0M

YoY+17.3%

United Health Pr's EBITDA was -$2.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 17.3% from the prior year.

Free Cash Flow

N/A

Net Income

-$2.0M

YoY+23.7%

United Health Pr reported -$2.0M in net income in fiscal year 2024. This represents an increase of 23.7% from the prior year.

EPS (Diluted)

$-0.01

YoY+0.0%

United Health Pr earned $-0.01 per diluted share (EPS) in fiscal year 2024. This represents an increase of 0.0% from the prior year.

Cash & Debt

$169K

YoY+77.0%

5Y CAGR+59.0%

10Y CAGR+35.2%

United Health Pr held $169K in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

252M

YoY+3.1%

5Y CAGR+7.2%

10Y CAGR+6.4%

United Health Pr had 252M shares outstanding in fiscal year 2024. This represents an increase of 3.1% from the prior year.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

R&D Spending

$356K

YoY-40.6%

5Y CAGR-11.8%

United Health Pr invested $356K in research and development in fiscal year 2024. This represents a decrease of 40.6% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

UEEC Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$0	$0-100.0%	$38K+63459.3%	$59-90.8%	$643-86.9%	$5K
Cost of Revenue	N/A	$0-100.0%	$19K+74476.0%	$25-87.2%	$195-85.2%	$1K
Gross Profit	N/A	$0-100.0%	$19K+55358.8%	$34-92.4%	$448-87.6%	$4K
R&D Expenses	$356K-40.6%	$599K-4.1%	$625K+163.0%	$237K-3.2%	$245K-63.2%	$666K
SG&A Expenses	$1.7M-9.6%	$1.8M-16.8%	$2.2M-92.6%	$29.6M+102.4%	$14.6M+168.9%	$5.4M
Operating Income	-$2.0M+17.3%	-$2.4M+13.4%	-$2.8M+90.6%	-$29.8M-100.7%	-$14.8M-143.7%	-$6.1M
Interest Expense	$32K-20.2%	$41K+138.0%	$17K-92.5%	$226K+7.7%	$210K	$0
Income Tax	$0	$0	$0	$0	$0	$0
Net Income	-$2.0M+23.7%	-$2.6M-55.5%	-$1.7M+94.5%	-$30.5M-94.4%	-$15.7M-138.0%	-$6.6M
EPS (Diluted)	$-0.010.0%	$-0.01	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$0	$0	$0	$0	$0	$0	$0	$0
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0
R&D Expenses	$25K-68.7%	$81K-30.3%	$116K+6.9%	$109K+65.5%	$66K-43.1%	$116K-24.6%	$153K+25.9%	$122K
SG&A Expenses	$208K+10.9%	$187K-86.4%	$1.4M+102.9%	$677K+99.3%	$339K+9.7%	$310K+5.5%	$293K-10.7%	$329K
Operating Income	-$233K+13.1%	-$268K+82.0%	-$1.5M-89.6%	-$785K-93.8%	-$405K+4.7%	-$425K+4.8%	-$447K+0.8%	-$450K
Interest Expense	$31K+22.2%	$25K+21.2%	$21K+118.4%	$9K+24.6%	$8K0.0%	$8K-5.7%	$8K-48.8%	$16K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$286K+9.4%	-$315K+79.4%	-$1.5M-88.1%	-$814K-88.4%	-$432K+4.4%	-$452K+4.2%	-$472K+2.8%	-$486K
EPS (Diluted)	$0.00	$0.00+100.0%	$-0.010.0%	$-0.01	$0.00	$0.00	N/A	$0.00

UEEC Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$270K-5.2%	$285K-18.8%	$351K+1208.0%	$27K-87.7%	$217K+132.3%	$93K
Current Assets	$192K+26.3%	$152K+113.7%	$71K+165.1%	$27K-76.8%	$116K+23.8%	$93K
Cash & Equivalents	$169K+77.0%	$95K+613.3%	$13K-38.6%	$22K-52.7%	$46K+177.2%	$17K
Inventory	$0-100.0%	$34K-3.3%	$35K	$0-100.0%	$70K-9.3%	$77K
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.7M+35.8%	$2.0M-17.2%	$2.4M+106.7%	$1.2M-0.1%	$1.2M+17.4%	$997K
Current Liabilities	$1.6M-15.9%	$2.0M-19.3%	$2.4M+106.7%	$1.2M-0.1%	$1.2M+17.4%	$997K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$2.4M-42.6%	-$1.7M+17.0%	-$2.1M-80.8%	-$1.1M-19.8%	-$953K-5.5%	-$904K
Retained Earnings	-$78.7M-2.6%	-$76.7M-3.5%	-$74.1M-2.3%	-$72.4M-73.0%	-$41.8M-60.1%	-$26.1M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$94K+15.7%	$82K-22.0%	$105K-61.3%	$270K+121.9%	$122K-47.8%	$233K-18.0%	$285K-15.2%	$336K
Current Assets	$43K+104.3%	$21K-39.8%	$35K-81.7%	$192K+629.0%	$26K-79.7%	$130K-14.6%	$152K+10.0%	$138K
Cash & Equivalents	$18K+8067.1%	$225-95.4%	$5K-97.1%	$169K+800.5%	$19K-76.8%	$81K-15.2%	$95K+28.9%	$74K
Inventory	N/A	N/A	N/A	$0	$0-100.0%	$34K0.0%	$34K0.0%	$34K
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.4M+5.6%	$3.3M+9.9%	$3.0M+9.1%	$2.7M+27.8%	$2.1M+4.7%	$2.0M+1.5%	$2.0M-5.6%	$2.1M
Current Liabilities	$2.0M+5.3%	$1.9M+5.4%	$1.8M+10.1%	$1.6M-21.5%	$2.1M+5.1%	$2.0M+2.0%	$2.0M-5.5%	$2.1M
Long-Term Debt	$928K+9.4%	$848K	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$3.3M-5.3%	-$3.2M-11.0%	-$2.9M-16.8%	-$2.4M-22.0%	-$2.0M-11.5%	-$1.8M-4.8%	-$1.7M+3.8%	-$1.8M
Retained Earnings	-$80.8M-0.4%	-$80.5M-0.4%	-$80.2M-1.9%	-$78.7M-1.4%	-$77.6M-0.6%	-$77.2M-0.6%	-$76.7M-0.6%	-$76.2M

UEEC Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$1.2M+45.7%	-$2.2M-255.1%	-$620K+25.2%	-$828K+37.5%	-$1.3M+25.0%	-$1.8M
Capital Expenditures	N/A	N/A	N/A	$0-100.0%	$101K	$0
Free Cash Flow	N/A	N/A	N/A	-$828K+42.0%	-$1.4M+19.2%	-$1.8M
Investing Cash Flow	$0+100.0%	-$3K+93.0%	-$41K	$0+100.0%	-$101K	$0
Financing Cash Flow	$1.3M-44.5%	$2.3M+250.7%	$652K-18.9%	$804K-44.8%	$1.5M-16.9%	$1.8M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	$0-100.0%	$50K	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	-$175K+5.2%	-$185K+32.6%	-$274K-51.0%	-$181K+36.9%	-$288K+29.1%	-$406K+29.6%	-$577K+4.7%	-$605K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	$0	$0	$0	$0	$0	$0	$0
Financing Cash Flow	$193K+7.4%	$180K+63.6%	$110K-64.1%	$307K+35.9%	$226K-42.3%	$391K-34.6%	$598K+9.7%	$545K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	$0	N/A

UEEC Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	50.3%-7.4pp	57.6%-12.0pp	69.7%-3.6pp	73.3%
Operating Margin	N/A	N/A	-7472.1%+50502078.8pp	-50509550.9%-48200273.9pp	-2309277.0%-2185588.9pp	-123688.1%
Net Margin	N/A	N/A	-4500.0%+51773776.3pp	-51778276.3%-49334823.7pp	-2443452.6%-2309450.2pp	-134002.3%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-741.4%+180.2pp	-921.6%-440.2pp	-481.4%+113512.3pp	-113993.7%-106756.8pp	-7236.9%-173.6pp	-7063.4%
Current Ratio	0.12+0.0	0.08+0.0	0.030.0	0.02-0.1	0.100.0	0.09
Debt-to-Equity	-1.11+0.1	-1.170.0	-1.17-0.1	-1.02+0.2	-1.23-0.1	-1.10
FCF Margin	N/A	N/A	N/A	-1403523.7%-1181562.3pp	-221961.4%-186102.6pp	-35858.8%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-302.8%+83.7pp	-386.6%+1078.6pp	-1465.1%-1163.6pp	-301.6%+53.5pp	-355.0%-161.3pp	-193.7%-27.9pp	-165.8%-21.1pp	-144.7%
Current Ratio	0.02+0.0	0.010.0	0.02-0.1	0.12+0.1	0.01-0.1	0.07-0.0	0.08+0.0	0.07
Debt-to-Equity	-0.28-0.0	-0.27+0.8	-1.04+0.1	-1.11-0.0	-1.06+0.1	-1.13+0.0	-1.17+0.0	-1.19
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$2.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.12), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Cardiac Biotech Solutions Inc CBSC

$6.6M

Encision ECIA

$6.4M

Reflect Scientfc RSCF

$5.1M

Cecors Inc CEOS

$2.2M

Wearable Health WHSI

$183K

Frequently Asked Questions

What is United Health Pr's annual revenue?

United Health Pr (UEEC) reported $0 in total revenue for fiscal year 2024. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is United Health Pr profitable?

No, United Health Pr (UEEC) reported a net income of -$2.0M in fiscal year 2024.

What is United Health Pr's earnings per share (EPS)?

United Health Pr (UEEC) reported diluted earnings per share of $-0.01 for fiscal year 2024. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is United Health Pr's EBITDA?

United Health Pr (UEEC) had EBITDA of -$2.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is United Health Pr's operating cash flow?

United Health Pr (UEEC) generated -$1.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are United Health Pr's total assets?

United Health Pr (UEEC) had $270K in total assets as of fiscal year 2024, including both current and long-term assets.

How much does United Health Pr spend on research and development?

United Health Pr (UEEC) invested $356K in research and development during fiscal year 2024.

How many shares does United Health Pr have outstanding?

United Health Pr (UEEC) had 252M shares outstanding as of fiscal year 2024.

What is United Health Pr's current ratio?

United Health Pr (UEEC) had a current ratio of 0.12 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is United Health Pr's debt-to-equity ratio?

United Health Pr (UEEC) had a debt-to-equity ratio of -1.11 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is United Health Pr's return on assets (ROA)?

United Health Pr (UEEC) had a return on assets of -741.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is United Health Pr's cash runway?

Based on fiscal year 2024 data, United Health Pr (UEEC) had $169K in cash against an annual operating cash burn of $1.2M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is United Health Pr's debt-to-equity ratio negative or unusual?

United Health Pr (UEEC) has negative shareholder equity of -$2.4M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is United Health Pr's Piotroski F-Score?

United Health Pr (UEEC) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are United Health Pr's earnings high quality?

United Health Pr (UEEC) has an earnings quality ratio of 0.60x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can United Health Pr cover its interest payments?

United Health Pr (UEEC) has an interest coverage ratio of -62.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.